Expert Ratings for Boston Scientific
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 16 Wall Street analysts have provided ratings for Boston Scientific (NYSE:BSX), with the majority being bullish. The average 12-month price target for BSX is $62.06, which is a 2.51% increase from the previous target of $60.54. Analysts play a crucial role in predicting stock performance, and their opinions are based on in-depth research, although they are subjective and should be considered as part of a broader investment strategy.
November 27, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has received predominantly bullish ratings from analysts, with an average 12-month price target of $62.06, indicating a positive outlook for the stock.
The positive analyst ratings and the increased price target suggest that the market sentiment for Boston Scientific is optimistic. This could lead to a short-term increase in the stock price as investors react to the favorable analyst coverage. However, the subjective nature of analyst ratings and the fact that they are only one of many factors investors consider should be taken into account.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100